FBLN1 and metabolic dysfunction-associated steatohepatitis: As shown in Figure 3A, the AUROCs for those proteins elevated in NASH patients with significant/advanced fibrosis (F2–F4) are 1.00 (Complement component C7), 0.87 (α-2-macroglobulin), and 0.79 (Fibulin-1), respectively.